Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
19 authors at 5 institutions in 1 country.
Elisa SchenaUnit of Bologna, CNR-National Research Council of Italy, Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", 40136 Bologna, Italy.ORCID 0000-0001-5960-4157
Elisabetta MattioliUnit of Bologna, CNR-National Research Council of Italy, Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", 40136 Bologna, Italy.
Chiara PeresUnit of Bologna, CNR-National Research Council of Italy, Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", 40136 Bologna, Italy.ORCID 0000-0003-0740-2013
Laura ZanottiUnit of Gynecology and Obstetrics, Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Paolo MorselliPlastic Surgery Unit, Department of Specialised, Experimental and Diagnostic Medicine, Alma Mater Studiorum University of Bologna, S. Orsola-Malpighi Hospital, 40126 Bologna, Italy.
Patricia IozzoCNR-National Research Council of Italy, Institute of Clinical Physiology, 56124 Pisa, Italy.ORCID 0000-0001-6443-7074
Maria Angela GuzzardiCNR-National Research Council of Italy, Institute of Clinical Physiology, 56124 Pisa, Italy.
Chiara BernardiniDepartment of Veterinary Medical Sciences, University of Bologna, 40064 Ozzano Emilia, Italy.ORCID 0000-0003-3384-0244
Monica ForniDepartment of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-1310-6202
Salvatore NesciDepartment of Veterinary Medical Sciences, University of Bologna, 40064 Ozzano Emilia, Italy.ORCID 0000-0001-8569-7158
Massimiliano CaprioLaboratory of Cardiovascular Endocrinology, IRCCS San Raffaele, 00163 Rome, Italy.ORCID 0000-0003-0722-7163
Carolina CecchettiUnit of Gynecology and Obstetrics, Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Uberto PagottoUnit of Gynecology and Obstetrics, Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0003-4182-3110
Elena GabusiSC Laboratorio di Immunoreumatologia e Rigenerazione Tissutale, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Luca CattiniSC Laboratorio di Immunoreumatologia e Rigenerazione Tissutale, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Gina LisignoliSC Laboratorio di Immunoreumatologia e Rigenerazione Tissutale, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.ORCID 0000-0003-2837-9967
William BlalockUnit of Bologna, CNR-National Research Council of Italy, Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", 40136 Bologna, Italy.ORCID 0000-0002-8045-4840
Alessandra GambineriUnit of Gynecology and Obstetrics, Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Giovanna LattanziUnit of Bologna, CNR-National Research Council of Italy, Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", 40136 Bologna, Italy.ORCID 0000-0002-7103-8722
Istituto Ortopedico Rizzoli · ITAzienda USL di Bologna · ITUniversity of Bologna · ITIstituto di Fisiologia Clinica · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT
Funding
AIPROSAB grant Prot. 3/2021 "TARGETS" and Prot. 3/2022 "PRE-RECEPTORSIRCCS San Raffaele Institutional fundings Ricerca corrente to M.C.Italian MUR PRIN Prot. 20223WFJJ3
6 · The paper itself
Abstract
Type-2 Familial Partial Lipodystrophy (FPLD2), a rare lipodystrophy caused by
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction. · full record | Socratic